The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.

cosmicsig: Mutational Signatures from COSMIC (Catalogue of Somatic Mutations in Cancer)

A data package with 2 main package variables: 'signature' and 'etiology'. The 'signature' variable contains the latest mutational signature profiles released on COSMIC <https://cancer.sanger.ac.uk/signatures/> for 3 mutation types: * Single base substitutions in the context of preceding and following bases, * Doublet base substitutions, and * Small insertions and deletions. The 'etiology' variable provides the known or hypothesized causes of signatures. 'cosmicsig' stands for COSMIC signatures. Please run ?'cosmicsig' for more information.

Version: 1.1.1
Depends: R (≥ 3.5)
Suggests: testthat (≥ 3.0.0), ICAMS, usethis
Published: 2023-08-30
DOI: 10.32614/CRAN.package.cosmicsig
Author: Steven Rozen ORCID iD [aut, cre], Nanhai Jiang ORCID iD [aut]
Maintainer: Steven Rozen <steverozen at pm.me>
BugReports: https://github.com/Rozen-Lab/cosmicsig/issues
License: GPL-3
URL: https://github.com/Rozen-Lab/cosmicsig
NeedsCompilation: no
Language: en-US
Citation: cosmicsig citation info
Materials: README NEWS
CRAN checks: cosmicsig results

Documentation:

Reference manual: cosmicsig.pdf

Downloads:

Package source: cosmicsig_1.1.1.tar.gz
Windows binaries: r-devel: cosmicsig_1.1.1.zip, r-release: cosmicsig_1.1.1.zip, r-oldrel: cosmicsig_1.1.1.zip
macOS binaries: r-release (arm64): cosmicsig_1.1.1.tgz, r-oldrel (arm64): cosmicsig_1.1.1.tgz, r-release (x86_64): cosmicsig_1.1.1.tgz, r-oldrel (x86_64): cosmicsig_1.1.1.tgz
Old sources: cosmicsig archive

Reverse dependencies:

Reverse suggests: mSigTools

Linking:

Please use the canonical form https://CRAN.R-project.org/package=cosmicsig to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.